Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Wants MedGuides Developed The Pre-FDAAA Way, Not Through REMS

This article was originally published in The Pink Sheet Daily

Executive Summary

Using 1998 authority would reduce the burden on sponsors, physicians and patients, industry group says.
Advertisement

Related Content

Eliminating MedGuide-Only REMS Merits PDUFA-Style Deadlines, PhRMA Says
FDA MedGuide Distribution Guidance May Mean Little Change For Manufacturers
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
CDER Eyes Prioritization, Timely Resolution Of Post-Marketing Safety Issues
REMS 2.0: FDA Refining New Drug Safety Tools
REMS And Benefits? FDA, Industry Debate Moving Beyond Safety Information
REMS Templates Get Nod From FDA, With Nudge From Pharmacists
"MedGuides" Required Only In Classes Where Patient Info Already Requested

Topics

Advertisement
UsernamePublicRestriction

Register

PS070960

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel